CVS Health Corp
CVS66.690USD
+1.659+2.55%
Handelsschluss 04/30, 16:00（ET）Kurse um 15 Minuten verzögert
84.03BMarktkapitalisierung
18.21KGV TTM
mehr Informationen über CVS Health Corp Unternehmen
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
Unternehmensinformationen
Unternehmens-codeCVS
Name des UnternehmensCVS Health Corp
IPO-datumOct 01, 1952
Gegründet am1996
CEOMr. J. David Joyner
Anzahl der mitarbeiter300000
WertpapierartOrdinary Share
GeschäftsjahresendeOct 01
Addresse1 Cvs Dr
StadtWOONSOCKET
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl02895-6146
Telefon14017651500
Websitehttps://cvshealth.com/
Unternehmens-codeCVS
IPO-datumOct 01, 1952
Gegründet am1996
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Larry Robbins
Mr. Larry Robbins
Independent Director
Independent Director
11.95M
--
Mr. Jean-Pierre (JP) Millon
Mr. Jean-Pierre (JP) Millon
Independent Director
Independent Director
112.22K
--
Mr. Tilak Mandadi
Mr. Tilak Mandadi
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
60.01K
+48.50%
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Lead Independent Director
Lead Independent Director
45.77K
+594.91%
Mr. Steven H. Nelson
Mr. Steven H. Nelson
Executive Vice President and President - Aetna
Executive Vice President and President - Aetna
21.33K
--
Ms. Mary L. Schapiro, J.D.
Ms. Mary L. Schapiro, J.D.
Independent Director
Independent Director
11.84K
--
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Independent Director
Independent Director
8.36K
--
Mr. Roger N. Farah
Mr. Roger N. Farah
Executive Chairman of the Board
Executive Chairman of the Board
4.12K
-92.40%
Ms. Alecia A. DeCoudreaux, J.D.
Ms. Alecia A. DeCoudreaux, J.D.
Independent Director
Independent Director
2.97K
--
Mr. Douglas H. (Doug) Shulman, J.D.
Mr. Douglas H. (Doug) Shulman, J.D.
Independent Director
Independent Director
2.20K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Larry Robbins
Mr. Larry Robbins
Independent Director
Independent Director
11.95M
--
Mr. Jean-Pierre (JP) Millon
Mr. Jean-Pierre (JP) Millon
Independent Director
Independent Director
112.22K
--
Mr. Tilak Mandadi
Mr. Tilak Mandadi
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
60.01K
+48.50%
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Lead Independent Director
Lead Independent Director
45.77K
+594.91%
Mr. Steven H. Nelson
Mr. Steven H. Nelson
Executive Vice President and President - Aetna
Executive Vice President and President - Aetna
21.33K
--
Ms. Mary L. Schapiro, J.D.
Ms. Mary L. Schapiro, J.D.
Independent Director
Independent Director
11.84K
--
Umsatzaufteilung
Währung: USDUpdate-Zeit: Sun, Apr 6
Währung: USDUpdate-Zeit: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Pharmacy
210.27B
56.40%
Premiums
122.90B
32.96%
Front Store
21.52B
5.77%
Other
15.97B
4.28%
Net investment income(loss)
2.15B
0.58%
Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Pharmacy
210.27B
56.40%
Premiums
122.90B
32.96%
Front Store
21.52B
5.77%
Other
15.97B
4.28%
Net investment income(loss)
2.15B
0.58%
Aktionäre
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
9.25%
Dodge & Cox
5.55%
Capital World Investors
4.84%
BlackRock Institutional Trust Company, N.A.
4.76%
State Street Global Advisors (US)
4.51%
Other
71.09%
Aktionärsstatistik
Aktionäre
Anteil
The Vanguard Group, Inc.
9.25%
Dodge & Cox
5.55%
Capital World Investors
4.84%
BlackRock Institutional Trust Company, N.A.
4.76%
State Street Global Advisors (US)
4.51%
Other
71.09%
Art
Aktionäre
Anteil
Investment Advisor/Hedge Fund
36.96%
Investment Advisor
35.24%
Hedge Fund
3.92%
Research Firm
3.04%
Pension Fund
2.50%
Bank and Trust
1.74%
Sovereign Wealth Fund
1.55%
Individual Investor
1.06%
Insurance Company
0.09%
Other
13.90%
Institutionelle Beteiligung
Update-Zeit: Sun, Jan 19
Update-Zeit: Sun, Jan 19
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
3710
1.09B
86.21%
+16.67M
2024Q4
3853
1.08B
85.46%
-1.57M
2024Q3
3812
1.05B
83.30%
-34.78M
2024Q2
3834
1.06B
84.02%
-4.44M
2024Q1
3863
1.03B
82.03%
-36.45M
2023Q4
3882
1.05B
81.65%
-1.13M
2023Q3
3770
1.04B
80.61%
-13.78M
2023Q2
3775
1.03B
80.60%
-13.09M
2023Q1
3785
1.03B
80.72%
-44.48M
2022Q4
3767
1.06B
81.84%
-22.75M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
116.76M
9.25%
-239.74K
-0.20%
Dec 31, 2024
Dodge & Cox
70.11M
5.55%
+7.08M
+11.23%
Dec 31, 2024
Capital World Investors
61.04M
4.84%
+12.82M
+26.58%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
60.09M
4.76%
+324.23K
+0.54%
Dec 31, 2024
State Street Global Advisors (US)
56.95M
4.51%
+425.05K
+0.75%
Dec 31, 2024
Geode Capital Management, L.L.C.
27.05M
2.14%
+689.87K
+2.62%
Dec 31, 2024
Capital International Investors
26.67M
2.11%
+1.21M
+4.76%
Dec 31, 2024
Fidelity Management & Research Company LLC
21.14M
1.67%
-697.46K
-3.19%
Dec 31, 2024
Pzena Investment Management, LLC
19.61M
1.55%
+6.48M
+49.30%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
18.70M
1.48%
+3.80M
+25.51%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
WBI Power Factor High Dividend ETF
6.23%
First Trust Consumer Staples Alphadex Fund
6.01%
Invesco S&P Ultra Dividend Revenue ETF
5.91%
Davis Select US Equity ETF
5.66%
iShares U.S. Healthcare Providers ETF
4.54%
VanEck Retail ETF
4.44%
iShares US Consumer Staples ETF
4.15%
iShares Large Cap Value Active ETF
3.42%
Invesco S&P 500 Enhanced Value ETF
3.42%
Burney US Factor Rotation ETF
3.42%
Mehr Anzeigen
WBI Power Factor High Dividend ETF
Anteil6.23%
First Trust Consumer Staples Alphadex Fund
Anteil6.01%
Invesco S&P Ultra Dividend Revenue ETF
Anteil5.91%
Davis Select US Equity ETF
Anteil5.66%
iShares U.S. Healthcare Providers ETF
Anteil4.54%
VanEck Retail ETF
Anteil4.44%
iShares US Consumer Staples ETF
Anteil4.15%
iShares Large Cap Value Active ETF
Anteil3.42%
Invesco S&P 500 Enhanced Value ETF
Anteil3.42%
Burney US Factor Rotation ETF
Anteil3.42%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
14.66B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Jan 03, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 03, 2025 going ex on Jan 23, 2025
Jan 23, 2025
Feb 03, 2025
Jan 23, 2025
Sep 19, 2024
CVS.NB Final Cash Dividend of gross USD 0.665 paid on Nov 01, 2024 going ex on Oct 21, 2024
Oct 21, 2024
Nov 01, 2024
Oct 21, 2024
Jul 08, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2024 going ex on Jul 22, 2024
Jul 22, 2024
Aug 01, 2024
Jul 22, 2024
Mar 21, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2024 going ex on Apr 19, 2024
Apr 22, 2024
May 01, 2024
Apr 19, 2024
Dec 06, 2023
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 01, 2024 going ex on Jan 19, 2024
Jan 22, 2024
Feb 01, 2024
Jan 19, 2024
Sep 21, 2023
CVS.NB Final Cash Dividend of gross USD 0.605 paid on Nov 01, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 01, 2023
Oct 19, 2023
Jul 07, 2023
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Aug 01, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 01, 2023
Jul 20, 2023
Mar 16, 2023
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on May 01, 2023 going ex on Apr 20, 2023
Apr 21, 2023
May 01, 2023
Apr 20, 2023
Dec 15, 2022
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Feb 01, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Feb 01, 2023
Jan 19, 2023
Sep 21, 2022
CVS.NB Final Cash Dividend of gross USD 0.55 paid on Nov 01, 2022 going ex on Oct 20, 2022
Oct 21, 2022
Nov 01, 2022
Oct 20, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten